CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.9. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.9. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Availability of funding for research
4.1.2. Technological advancements & new product launches
4.1.3. Growing awareness of 3D cell culture
4.1.4. Focus on developing alternatives to animal testing
4.2. Market Restraints & Challenges
4.2.1. Lack of consistency in 3D cell culture products
4.2.2. Lack of infrastructure
4.3. Market Opportunities
4.3.1. Regenerative medicine, an alternative to organ transplantation
4.3.2. The emergence of microfluidics-based 3D cell culture
CHAPTER 5. GLOBAL 3D CELL CULTURE MARKET- BY PRODUCT
5.1. Introduction
5.2. Scaffold-free 3d cell culture
5.2.1. 3d bioreactors
5.2.2. 3d Petri dishes
5.2.3. Low-adhesion microplates
5.2.4. Hanging drop plates
5.3. Scaffold-based 3d cell culture
5.3.1. Micropatterned surfaces
5.3.2. Solid scaffolds
5.3.3. Hydrogels/ECM analogs
5.4. Microfluidics-based 3d cell culture
5.5. Magnetic levitation & 3d bioprinting
CHAPTER 6. GLOBAL 3D CELL CULTURE MARKET – BY APPLICATION
6.1. Introduction
6.2. Tissue engineering and regenerative medicine
6.3. Drug discovery and toxicology testing
6.4. Cancer and stem cell research
CHAPTER 7. GLOBAL 3D CELL CULTURE MARKET – BY END USER
7.1. Introduction
7.2. Pharmaceutical & biotechnology companies
7.3. Research institutes
CHAPTER 8. GLOBAL 3D CELL CULTURE MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.9. Middle East & Africa
8.9.1. UAE
8.9.2. Saudi Arabia
8.9.3. Iran
8.9.4. Iraq
8.9.5. Qatar
8.9.6. South Africa
8.9.7. Algeria
8.9.8. Morocco
8.9.9. Nigeria
8.9.10. Egypt
8.9.11. Others
CHAPTER 9. GLOBAL 3D CELL CULTURE MARKET - COMPANY PROFILES
9.1. Thermo Fisher Scientific, Inc.
9.2. Becton, Dickinson and Company
9.3. Nano 3D Biosciences.
9.4. Promocell GmbH.
9.5. Corning Inc.
9.6. 3D Biomatrix Inc.
9.7. Lonza Group.
9.8. VWR International, LLC.
9.9. Tecan Trading AG.
9.10. 3D Biotek LLC.
9.11. Global Cell Solutions, Inc.
9.12. InSphero AG.
9.13. Hamilton.
9.14. The Merck Group.
9.15. Repro CELL Inc.
CHAPTER 10. GLOBAL 3D CELL CULTURE MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
